Positive context积极背景
Stocks股票 / Health Care / BIOA
BioAge Labs Inc · Health Care
BIOA US listed · USD美股 · 美元
Health Care
Russell 2000罗素2000
Speculative / unprofitable投机／未盈利
$5.54
Regular quote常规时段报价
-$0.41 · -6.89%
Extended quote unavailable. Showing the regular quote.盘前盘后报价暂不可用，现显示常规时段报价。
Pre-market盘前
·
52w low52周低 $4.58high高 $25.80
Neutral — no clear edge中性 — 无明显优势
A normal mid-cycle dip below the 10-day average — the real cycle low isn't due for ~9+ trading days. Wait for support to hold, or for the next low to set up.这是跌破 10 日均线的正常周期中段回调——真正的周期低点要到约 9+ 个交易日后才会到来。等待支撑站稳，或等下一个低点构筑成形。
As of 2026-11-05截至 2026-11-05
Company news公司新闻
The latest reporting最新报道
One story, with the reporting behind it.将同一事件汇总，保留各来源报道。
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-11-05
Momentum (RSI 14)动量（RSI 14）
39
Depressed偏低
vs 50-day average相对50日均线
-21.8% below下方
Below trend跌破趋势
vs 200-day average相对200日均线
-64.3% below下方
Long trend down长期向下
Volatility波动率
71th percentile第71百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
Post-earnings drift: -13.2% (20d)财报后漂移：-13.2%（20日）
Financials财务数据
fiscal years财年Revenue营业收入
$9.0M2025
20242025
Earnings per share每股收益
$-2.242025
20242025
Free cash flow自由现金流
-$82.3M2025
20242025
Operating margin营业利润率
-1031.5%
Net margin净利率
-896.1%
FCF margin自由现金流利润率
-907.5%
Balance-sheet quality财务体质 2/7
Return on equity股本回报率 -30%
Watch关注
Leverage杠杆
Current ratio流动比率14.24
Capital allocation资本配置
Stock-based comp股权薪酬$11.7M
Share count change (1y)股数变化（1年）+4.3%
Debt coming due到期债务
FY2025 10-KIn the 12-month bucket following fiscal period end 2025-12-31, it reported $2.0M due — about 100% of its disclosed principal.在财年期末 2025-12-31 之后12个月的区间内，已披露到期本金为 $2.0M，约占其披露本金的 100%。
All maturity buckets are measured from fiscal period end 2025-12-31, not from today.所有到期区间均从财年期末 2025-12-31 起算，而非从今天起算。
First 12 months after period end报告期末之后首12个月
$2.0M
Year 2第2年
not reported未披露
Year 3第3年
not reported未披露
Year 4第4年
not reported未披露
Year 5第5年
not reported未披露
After year 55年以后
not reported未披露
Cash reported at 2025-12-31: $188888000.截至 2025-12-31 披露的现金：$188888000。 At the cash-burn pace reported over 2025-01-01 to 2025-12-31, that cash represented about 27.5 months. This scenario excludes debt payments and future financing.按 2025-01-01 至 2025-12-31 期间披露的现金消耗速度，该现金约对应 27.5 个月。此情景不包括债务偿还与未来融资。
Capital-need coverage is partial; incomplete or incompatible filing inputs are not combined.资本需求覆盖信息不完整；不会合并不完整或不兼容的报告数据。
Any available cash-flow scenario is context only. Missing or incompatible inputs are not replaced with zero or a financing forecast.可用现金流情景仅供参考；缺失或不兼容的输入不以零值或融资预测替代。
Sources and cash-flow calculation来源与现金流计算
Figures are XBRL facts from one filing — no two years are mixed. Filing数据取自同一份文件中的 XBRL 事实，不跨文件拼接。文件
0001193125-26-120873, period ending报告期截至 2025-12-31, unit单位 USD.
Cache acquired缓存获取时间: 2026-10-23T08:00:13.566483+00:00.
1/6 buckets reported.个区间有披露。
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo— period_mismatchLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree— absentLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour— absentLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive— absentLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive— absent
Annual period年度区间 2025-01-01 — 2025-12-31 · USD · 10-K · 0001193125-26-120873 · Filed提交日期 2026-03-24.
Cache acquired缓存获取时间: 2026-10-23T08:00:13.566483+00:00 · Evaluated as of评估截至 2026-11-06.
- Reported operating cash flow已披露经营活动现金流: $-81627000
- Reported equipment spending (capex outflow)已披露设备支出（资本开支流出）: $719000
- Derived free cash flow (operating cash flow minus capex)计算所得自由现金流（经营现金流减资本开支）: $-82346000
Cash is the reported balance at period end. The runway scenario holds this annual cash-flow pace constant and excludes debt payments, restricted-cash adjustments and future financing.现金为期末已披露余额。现金跑道情景假设本年度现金流速度保持不变，不包括债务偿还、受限现金调整与未来融资。
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
DOWNTREND → UNCONFIRMED TURN下跌趋势 → 未确认转向
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$1.7M net (0 buyers, 2 sellers)-$1.7M 净值（0 买家，2 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| RA Capital Management | D | Holding持有 | 0.4% | 2026-06-30 |
Signal history信号历史
engine events引擎事件
UPTREND → NEARING A LOW上涨趋势 → 接近低点
GET READY. Mixed structure. Last cycle was left-translated (topped early) — a bearish structural tell准备。结构混合。 上一周期为左移结构（见顶偏早）——属于看空的结构性信号
Oct 27, 2026
DOWNTREND → UNCONFIRMED TURN下跌趋势 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Oct 23, 2026
BIOA RSI reached oversoldBIOA RSI进入超卖
RSI(14) crossed below 30 — washed out; context, not a timing trigger alone. $5.10.RSI(14)下穿30 — 超卖；仅作背景，单独不构成择时。$5.10。
Oct 20, 2026
BIOA daily MACD crossed upBIOA 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $5.56.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$5.56。
Oct 20, 2026
BIOA StochRSI turned up from oversoldBIOA StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $5.56.StochRSI重回20上方 — 下行动量趋缓的最早预警。$5.56。
Oct 16, 2026
BIOA printed a daily-cycle lowBIOA 打出日线周期低点
A confirmed local low — in this cycle framework the highest-odds long-entry window. $4.84.一个已确认的局部低点 — 在本周期框架中做多胜率最高的入场窗口。$4.84。
Oct 16, 2026
BIOA made a new 52-week lowBIOA 创52周新低
Price reached a fresh 52-week low — a momentum / trend extreme the whole market watches. $4.84.价格创出52周新低 — 全市场关注的动量/趋势极值。$4.84。
Oct 16, 2026
BIOA daily MACD crossed downBIOA 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $4.84.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$4.84。
Sep 24, 2026
BIOA RSI reached oversoldBIOA RSI进入超卖
RSI(14) crossed below 30 — washed out; context, not a timing trigger alone. $7.21.RSI(14)下穿30 — 超卖；仅作背景，单独不构成择时。$7.21。
Sep 23, 2026
UNCONFIRMED TURN → DOWNTREND未确认转向 → 下跌趋势
AVOID回避
Sep 18, 2026
BIOA StochRSI turned up from oversoldBIOA StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $8.06.StochRSI重回20上方 — 下行动量趋缓的最早预警。$8.06。
Sep 18, 2026
BIOA RSI reached oversoldBIOA RSI进入超卖
RSI(14) crossed below 30 — washed out; context, not a timing trigger alone. $8.06.RSI(14)下穿30 — 超卖；仅作背景，单独不构成择时。$8.06。
Showing the last 15 of显示最近15条，共 154 signals条信号
Company profile公司档案
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -6.7% | -4.7% |
| 1 Month近1月 | -11.9% | -5.9% |
| 3 Months近3月 | -52.7% | -5.0% |
| 6 Months近6月 | -69.2% | -0.1% |
| Year to date年初至今 | -56.8% | +8.1% |
| 1 Year近1年 | -26.1% | +9.3% |
Trading information交易信息
Volatility rank波动率分位
71th pctile
EPS (trailing)每股收益
$-2.16
Off 52-week high距52周高点
-77.9%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20242024 | 20252025 | |
|---|---|---|
| Revenue营业收入 | — | $9M |
| EPS每股收益 | $-6.63 | $-2.24 |
| Free cash flow自由现金流 | $-52M | $-82M |
| Gross margin毛利率 | — | — |
| Net margin净利率 | — | -896.1% |
| FCF margin自由现金流利润率 | — | -915.5% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$9M
Net income净利润
$-81M
Operating cash flow经营现金流
$-82M
Total assets总资产
$295M
Shareholder equity股东权益
$272M
Long-term debt长期负债
$0
Shares outstanding总股本
0.04B
Returns & growth回报与增长
Return on equity股本回报率
-29.6%
Return on assets资产回报率
-27.3%
Debt / assets负债/资产
0.0%
Asset growth资产增速
-17.7%
Accounting quality checks会计质量检查
- Earnings quality: accruals near the peer median盈利质量：应计利润接近同业中位
- Capital discipline: investment near the peer median资本纪律：投资力度接近同业中位
- Balance sheet: leverage unremarkable资产负债表：杠杆水平一般
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
39
RSI (2-day)RSI（2日）
11
vs 20-day average相对20日均线
-0.7%
vs 50-day average相对50日均线
-21.8%
vs 200-day average相对200日均线
-64.3%
Golden cross (50>200)金叉（50>200）
not in effect未生效
MACDMACD
above signal位于信号线上方
Timeframe alignment多周期共振
Daily日线
momentum up动能向上
3-day3日线
momentum up — fresh upturn动能向上——刚刚转强
Weekly周线
momentum down — turning up soon动能向下——接近转强
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range width percentile波幅宽度分位
43/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| RA Capital Management | D | Holding持有 | 0.4% | $41M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
1
Buying vs selling买入vs卖出
0 : 0
Quarterly trend季度趋势
{'direction': 'distributing', 'n_quarters': 7, 'holders_first': 3, 'holders_last': 1, 'holders_delta': -2, 'value_change_pct': -55.2, 'from_period': '2024-09-30', 'to_period': '2026-03-31', 'available_on': '2026-05-16', 'available_on_first': '2024-11-15', 'holders_series': [3, 2, 2, 0, 0, 0, 1]}{'direction': 'distributing', 'n_quarters': 7, 'holders_first': 3, 'holders_last': 1, 'holders_delta': -2, 'value_change_pct': -55.2, 'from_period': '2024-09-30', 'to_period': '2026-03-31', 'available_on': '2026-05-16', 'available_on_first': '2024-11-15', 'holders_series': [3, 2, 2, 0, 0, 0, 1]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$1.7M
Insider buyers vs sellers内部人买家vs卖家
0 : 2
Recent fund flows近期基金流向
SPDR S&P PharmaceuticalsSPDR S&P Pharmaceuticals
accumulating持续增持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。